Credit Suisse’s Invacare Corporation IVC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-18
| Closed | – | – | 4480 |
|
|
2022
Q2 | $0 | Buy |
+18
| New | +$24 | ﹤0.01% | 4545 |
|
|
2021
Q1 | – | Sell |
-10,901
| Closed | -$98K | – | 4655 |
|
|
2020
Q4 | $98K | Sell |
10,901
-144
| -1% | -$1.2K | ﹤0.01% | 4183 |
|
|
2020
Q3 | $83K | Buy |
+11,045
| New | +$76.6K | ﹤0.01% | 3936 |
|
|
2019
Q4 | – | Sell |
-12,547
| Closed | -$94K | – | 4386 |
|
|
2019
Q3 | $94K | Buy |
+12,547
| New | +$70.4K | ﹤0.01% | 3977 |
|
|
2019
Q2 | – | Sell |
-39,050
| Closed | -$327K | – | 4277 |
|
|
2019
Q1 | $327K | Sell |
39,050
-15,770
| -29% | -$114K | ﹤0.01% | 3561 |
|
|
2018
Q4 | $236K | Sell |
54,820
-274
| -0.5% | -$2.42K | ﹤0.01% | 3608 |
|
|
2018
Q3 | $802K | Sell |
55,094
-7,459
| -12% | -$124K | ﹤0.01% | 3022 |
|
|
2018
Q2 | $1.16M | Buy |
62,553
+8,031
| +15% | +$145K | ﹤0.01% | 2897 |
|
|
2018
Q1 | $949K | Buy |
54,522
+5,629
| +12% | +$99.2K | ﹤0.01% | 2991 |
|
|
2017
Q4 | $823K | Sell |
48,893
-9,434
| -16% | -$154K | ﹤0.01% | 3131 |
|
|
2017
Q3 | $919K | Buy |
58,327
+16,977
| +41% | +$242K | ﹤0.01% | 3160 |
|
|
2017
Q2 | $546K | Sell |
41,350
-3,179
| -7% | -$41.8K | ﹤0.01% | 3098 |
|
|
2017
Q1 | $530K | Sell |
44,529
-7,275
| -14% | -$87.2K | ﹤0.01% | 3242 |
|
|
2016
Q4 | $675K | Buy |
51,804
+5,121
| +11% | +$58.9K | ﹤0.01% | 3287 |
|
|
2016
Q3 | $521K | Buy |
46,683
+3,396
| +8% | +$40.9K | ﹤0.01% | 3394 |
|
|
2016
Q2 | $525K | Sell |
43,287
-10,503
| -20% | -$124K | ﹤0.01% | 3394 |
|
|
2016
Q1 | $709K | Buy |
53,790
+5,511
| +11% | +$78.2K | ﹤0.01% | 2988 |
|
|
2015
Q4 | $840K | Sell |
48,279
-1,660
| -3% | -$30K | ﹤0.01% | 2963 |
|
|
2015
Q3 | $722K | Buy |
49,939
+2,962
| +6% | +$51.8K | ﹤0.01% | 3119 |
|
|
2015
Q2 | $1.02M | Buy |
46,977
+16,019
| +52% | +$339K | ﹤0.01% | 3167 |
|
|
2015
Q1 | $601K | Sell |
30,958
-11,685
| -27% | -$202K | ﹤0.01% | 3415 |
|
|
2014
Q4 | $715K | Sell |
42,643
-2,845
| -6% | -$43.2K | ﹤0.01% | 3430 |
|
|
2014
Q3 | $537K | Sell |
45,488
-13,547
| -23% | -$206K | ﹤0.01% | 3593 |
|
|
2014
Q2 | $1.09M | Sell |
59,035
-6,776
| -10% | -$115K | ﹤0.01% | 3202 |
|
|
2014
Q1 | $1.25M | Sell |
65,811
-16,099
| -20% | -$331K | ﹤0.01% | 2912 |
|
|
2013
Q4 | $1.9M | Buy |
81,910
+31,188
| +61% | +$646K | ﹤0.01% | 2692 |
|
|
2013
Q3 | $876K | Buy |
50,722
+4,462
| +10% | +$70.9K | ﹤0.01% | 3069 |
|
|
2013
Q2 | $664K | Buy |
+46,260
| New | +$641K | ﹤0.01% | 3098 |
|
Other funds holding IVC
RCM
AGAM
HCM
Credit Suisse's IVC Position: Q3 2022 in Review
Credit Suisse sold out of Invacare Corporation (IVC) in Q3 2022, closing a stake of 18 shares.
Credit Suisse first reported a position in IVC in Q2 2013 and held it in 28 quarters. The position peaked at $1.9M in Q4 2013. 72 funds tracked by Wall St. Rank hold IVC as of Q3 2022.
- Credit Suisse reported no remaining Invacare Corporation position as of Q3 2022 after selling out during the quarter.
- Credit Suisse sold 18 Invacare Corporation shares in Q3 2022.
- Credit Suisse first reported a position in Invacare Corporation in Q2 2013 and held it in 28 quarters.
- Credit Suisse's Invacare Corporation position peaked at $1.9M in Q4 2013.
- 72 funds tracked by Wall St. Rank held Invacare Corporation as of Q3 2022.
Based on Credit Suisse's 13F filing for Q3 2022, filed 10 Nov 2022.